Table 2.
Metabolic pathways significantly enriched for differences between control and docetaxel treated OCCs
| KEGG pathway | Raw p | FDR |
|---|---|---|
| Tyrosine metabolism | 1.03E-03 | 0.030 |
| Butanoate metabolism | 1.87E-03 | 0.030 |
| Phenylalanine metabolism | 1.93E-03 | 0.030 |
| Citrate cycle (TCA cycle) | 3.35E-03 | 0.037 |
| Glutathione metabolism | 6.36E-03 | 0.037 |
| Nicotinate and nicotinamide metabolism | 6.60E-03 | 0.037 |
| Thiamine metabolism | 7.52E-03 | 0.037 |
| Alanine, aspartate and glutamate metabolism | 7.73E-03 | 0.037 |
| Pyrimidine metabolism | 9.01E-03 | 0.038 |
| Arginine and proline metabolism | 0.011 | 0.038 |
| Beta-Alanine metabolism | 0.012 | 0.038 |
| Pantothenate and CoA biosynthesis | 0.012 | 0.038 |
| Aminoacyl-tRNA biosynthesis | 0.013 | 0.038 |
| Nitrogen metabolism | 0.016 | 0.046 |
| Purine metabolism | 0.017 | 0.046 |